About
Nasal Spray Epinephrine
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationSan Diego & Southern California
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
751
By Phase
PHASE2: 4PHASE4: 1PHASE1: 3
By Status
COMPLETED: 3RECRUITING: 2WITHDRAWN: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06927999Lead Sponsor
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
PHASE2Recruiting
42 participants
Started: Jul 9, 2025 · Completed: Jun 30, 2026
NCT06834165Lead Sponsor
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
PHASE4Not yet recruiting
600 participants
Started: Apr 30, 2025 · Completed: Jun 30, 2026
NCT06705998Lead Sponsor
To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
PHASE1Recruiting
52 participants
Started: Dec 4, 2024 · Completed: Jul 30, 2026
NCT05203367Lead Sponsor
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
PHASE1Withdrawn
Started: Nov 25, 2022 · Completed: Mar 30, 2023
NCT05363670Lead Sponsor
Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
PHASE2Completed
18 participants
Started: Jul 28, 2022 · Completed: Feb 2, 2024
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...